Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hedgehog Pathway Inhibitors as Targeted Cancer Therapy and Strategies to Overcome Drug Resistance
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 23, Issue 3, Pages 1733
Publisher
MDPI AG
Online
2022-02-03
DOI
10.3390/ijms23031733
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a potent antagonist of smoothened in hedgehog signaling
- (2021) Junwan Fan et al. Cell and Bioscience
- GLI1: A Therapeutic Target for Cancer
- (2021) Justin T. Avery et al. Frontiers in Oncology
- Clues to primary vismodegib resistance lie in histology and genetics
- (2020) Qisi Sun et al. JOURNAL OF CLINICAL PATHOLOGY
- Pharmacophore-Based Virtual Screening for Identification of Negative Modulators of GLI1 as Potential Anticancer Agents
- (2020) Fabrizio Manetti et al. ACS Medicinal Chemistry Letters
- ABT-199 inhibits Hedgehog pathway by acting as a competitive inhibitor of oxysterol, rather as a BH3 mimetic
- (2020) Juan Wang et al. ACTA PHARMACOLOGICA SINICA
- Of mitogens and morphogens: modelling Sonic Hedgehog mechanisms in vertebrate development
- (2020) Ian Groves et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- AP-1 and TGFß cooperativity drives non-canonical Hedgehog signaling in resistant basal cell carcinoma
- (2020) Catherine D. Yao et al. Nature Communications
- Glabrescione B delivery by self-assembling micelles efficiently inhibits tumor growth in preclinical models of Hedgehog-dependent medulloblastoma
- (2020) Paola Infante et al. CANCER LETTERS
- A large-scale drug screen identifies selective inhibitors of class I HDACs as a potential therapeutic option for SHH medulloblastoma
- (2019) Ekaterina Pak et al. NEURO-ONCOLOGY
- Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
- (2019) Silvia Pietrobono et al. Frontiers in Genetics
- Molecular basis of drug resistance in smoothened receptor: An in silico study of protein resistivity and specificity
- (2019) Noopur Sinha et al. PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
- Novel-smoothened inhibitors for therapeutic targeting of naïve and drug-resistant hedgehog pathway-driven cancers
- (2018) Qing-rou Li et al. ACTA PHARMACOLOGICA SINICA
- Casein kinase 1α: biological mechanisms and theranostic potential
- (2018) Shaojie Jiang et al. Cell Communication and Signaling
- Discovery of a potent hedgehog pathway inhibitor capable of activating caspase8-dependent apoptosis
- (2018) Qin Chen et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- An exploratory open-label, investigator-initiated study to evaluate the efficacy and safety of combination sonidegib and buparlisib for advanced basal cell carcinomas
- (2018) Duy Cong Tran et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy, Safety, and Comparison of Sonic Hedgehog Inhibitors in Basal Cell Carcinomas: A Systematic Review and Meta-Analysis
- (2018) Pingxing Xie et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Strategies to target the Hedgehog signaling pathway for cancer therapy
- (2018) Minhang Xin et al. MEDICINAL RESEARCH REVIEWS
- Noncanonical hedgehog pathway activation through SRF–MKL1 promotes drug resistance in basal cell carcinomas
- (2018) Ramon J Whitson et al. NATURE MEDICINE
- Molecular modeling study on resistance of WT/D473H SMO to antagonists LDE-225 and LEQ-506
- (2018) Jing Tu et al. PHARMACOLOGICAL RESEARCH
- Current trends in Hedgehog signaling pathway inhibition by small molecules
- (2018) Francesca Ghirga et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Hedgehog pathway inhibitors of the acylthiourea and acylguanidine class show antitumor activity on colon cancer in vitro and in vivo
- (2018) Loredana Vesci et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma
- (2018) Jezabel Rodriguez-Blanco et al. CLINICAL CANCER RESEARCH
- Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity
- (2018) Heng Zhang et al. Future Medicinal Chemistry
- Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
- (2018) Jorge E. Cortes et al. LEUKEMIA
- Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors
- (2017) Miroslava Didiasova et al. FASEB JOURNAL
- Long-term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30-month analysis of the randomized phase 2 BOLT study
- (2017) J.T. Lear et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial
- (2017) Andrew D Zelenetz et al. LANCET ONCOLOGY
- A Transposon Screen Identifies Loss of Primary Cilia as a Mechanism of Resistance to SMO Inhibitors
- (2017) Xuesong Zhao et al. Cancer Discovery
- The safety of IPI-926, a novel hedgehog pathway inhibitor, in combination with gemcitabine in patients (pts) with metastatic pancreatic cancer.
- (2017) J. Stephenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Cyclopamine tartrate, an inhibitor of Hedgehog signaling, strongly interferes with mitochondrial function and suppresses aerobic respiration in lung cancer cells
- (2016) Md Maksudul Alam et al. BMC CANCER
- Inhibition of the hedgehog pathway in patients with basal-cell nevus syndrome: final results from the multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
- (2016) Jean Y Tang et al. LANCET ONCOLOGY
- Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma
- (2016) Ximena Bonilla et al. NATURE GENETICS
- Mechanism of inhibition of the tumor suppressor Patched by Sonic Hedgehog
- (2016) Hanna Tukachinsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Primary Cilia and Mammalian Hedgehog Signaling
- (2016) Fiona Bangs et al. Cold Spring Harbor Perspectives in Biology
- In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors
- (2016) Monica Benvenuto et al. Oncotarget
- DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance
- (2016) Wolfgang Gruber et al. Oncotarget
- Effects of Combined Treatment With Arsenic Trioxide and Itraconazole in Patients With Refractory Metastatic Basal Cell Carcinoma
- (2016) Mina S. Ally et al. JAMA Dermatology
- Multiple Hereditary Infundibulocystic Basal Cell Carcinoma Syndrome Associated With a GermlineSUFUMutation
- (2016) Joshua M. Schulman et al. JAMA Dermatology
- Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
- (2015) Scott X. Atwood et al. CANCER CELL
- Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
- (2015) Hayley J. Sharpe et al. CANCER CELL
- RAS/MAPK Activation Drives Resistance to Smo Inhibition, Metastasis, and Tumor Evolution in Shh Pathway-Dependent Tumors
- (2015) X. Zhao et al. CANCER RESEARCH
- An Investigator-Initiated Open-Label Trial of Sonidegib in Advanced Basal Cell Carcinoma Patients Resistant to Vismodegib
- (2015) C. Danial et al. CLINICAL CANCER RESEARCH
- MRT-92 inhibits Hedgehog signaling by blocking overlapping binding sites in the transmembrane domain of the Smoothened receptor
- (2015) Lucile Hoch et al. FASEB JOURNAL
- Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial
- (2015) Michael R Migden et al. LANCET ONCOLOGY
- Regulation of the oncoprotein Smoothened by small molecules
- (2015) Hayley J Sharpe et al. Nature Chemical Biology
- Non-Canonical Hh Signaling in Cancer—Current Understanding and Future Directions
- (2015) Dongsheng Gu et al. Cancers
- Scaffold hopping approach to a new series of smoothened antagonists
- (2014) Wenfeng Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Genome Sequencing of SHH Medulloblastoma Predicts Genotype-Related Response to Smoothened Inhibition
- (2014) Marcel Kool et al. CANCER CELL
- Hedgehog-GLI Signaling Inhibition Suppresses Tumor Growth in Squamous Lung Cancer
- (2014) L. Huang et al. CLINICAL CANCER RESEARCH
- Discontinued in 2013: oncology drugs
- (2014) Robert Williams EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Hedgehog signaling pathway: A novel target for cancer therapy: Vismodegib, a promising therapeutic option in treatment of basal cell carcinomas
- (2014) Afroz Abidi INDIAN JOURNAL OF PHARMACOLOGY
- Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
- (2014) Daniel J. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
- (2014) Sabrina Pricl et al. Molecular Oncology
- Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
- (2014) Chong Wang et al. Nature Communications
- Itraconazole and Arsenic Trioxide Inhibit Hedgehog Pathway Activation and Tumor Growth Associated with Acquired Resistance to Smoothened Antagonists
- (2013) James Kim et al. CANCER CELL
- Discovery of NVP-LEQ506, a Second-Generation Inhibitor of Smoothened
- (2013) Stefan Peukert et al. ChemMedChem
- U.S. Food and Drug Administration Approval: Vismodegib for Recurrent, Locally Advanced, or Metastatic Basal Cell Carcinoma
- (2013) M. Axelson et al. CLINICAL CANCER RESEARCH
- Inhibition mechanism exploration of investigational drug TAK-441 as inhibitor against Vismodegib-resistant Smoothened mutant
- (2013) Tsuyoshi Ishii et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Hedgehog Signaling Pathway in Ovarian Cancer
- (2013) Joanna Szkandera et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
- (2013) Scott X. Atwood et al. NATURE
- Structure of the human smoothened receptor bound to an antitumour agent
- (2013) Chong Wang et al. NATURE
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- The mechanisms of Hedgehog signalling and its roles in development and disease
- (2013) James Briscoe et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation
- (2013) F Wolff et al. ONCOGENE
- Initial Assessment of Tumor Regrowth After Vismodegib in Advanced Basal Cell Carcinoma
- (2012) Anne Lynn S. Chang et al. ARCHIVES OF DERMATOLOGY
- Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors
- (2012) Tomohiro Ohashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
- (2012) Yan Wang et al. CANCER CELL
- Basal cell carcinoma — molecular biology and potential new therapies
- (2012) Maria Kasper et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
- (2012) Aleksandar Sekulic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Hedgehog pathway inhibitor saridegib (IPI-926) increases lifespan in a mouse medulloblastoma model
- (2012) M. J. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hedgehog Signal Transduction Network
- (2012) D. J. Robbins et al. Science Signaling
- Hedgehog pathway as a drug target: Smoothened inhibitors in development
- (2012) Tara Lin et al. OncoTargets and Therapy
- Hedgehog signaling in cholangiocytes
- (2011) Alessia Omenetti et al. CURRENT OPINION IN GASTROENTEROLOGY
- Myofibroblast-derived PDGF-BB promotes hedgehog survival signaling in cholangiocarcinoma cells
- (2011) Christian D. Fingas et al. HEPATOLOGY
- Heterotrimeric GiProteins Link Hedgehog Signaling to Activation of Rho Small GTPases to Promote Fibroblast Migration
- (2011) Ariel H. Polizio et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
- (2011) Paul W Noble et al. LANCET
- Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
- (2011) Michael J. Munchhof et al. ACS Medicinal Chemistry Letters
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Small Molecule Inhibition of GDC-0449 Refractory Smoothened Mutants and Downstream Mechanisms of Drug Resistance
- (2010) Gerrit J. P. Dijkgraaf et al. CANCER RESEARCH
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Histone deacetylase and Cullin3–RENKCTD11 ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation
- (2010) Gianluca Canettieri et al. NATURE CELL BIOLOGY
- The primary cilium: a signalling centre during vertebrate development
- (2010) Sarah C. Goetz et al. NATURE REVIEWS GENETICS
- DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS
- (2010) Matthias Lauth et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector
- (2010) J. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interfering with Resistance to Smoothened Antagonists by Inhibition of the PI3K Pathway in Medulloblastoma
- (2010) S. Buonamici et al. Science Translational Medicine
- Discovery of NVP-LDE225, a Potent and Selective Smoothened Antagonist
- (2010) Shifeng Pan et al. ACS Medicinal Chemistry Letters
- Review: Targeting the Hedgehog pathway in cancer
- (2010) Sachin Gupta et al. Therapeutic Advances in Medical Oncology
- Paracrine Hedgehog Signaling in Cancer
- (2009) J.-W. Theunissen et al. CANCER RESEARCH
- Hedgehog signalling in breast cancer
- (2009) M. Kasper et al. CARCINOGENESIS
- A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
- (2009) Barbara Stecca et al. EMBO JOURNAL
- Hedgehog signalling in colon cancer and stem cells
- (2009) Alberto Gulino et al. EMBO Molecular Medicine
- GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
- (2009) O. Nolan-Stevaux et al. GENES & DEVELOPMENT
- 1-Amino-4-benzylphthalazines as Orally Bioavailable Smoothened Antagonists with Antitumor Activity
- (2009) Karen Miller-Moslin et al. JOURNAL OF MEDICINAL CHEMISTRY
- Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer
- (2009) Motoko Seto et al. MOLECULAR CARCINOGENESIS
- Sonic Hedgehog Guides Axons through a Noncanonical, Src-Family-Kinase-Dependent Signaling Pathway
- (2009) Patricia T. Yam et al. NEURON
- Design and Synthesis of Inhibitors of Hedgehog Signaling Based on the Alkaloid Cyclopamine
- (2009) Jeffrey D. Winkler et al. ORGANIC LETTERS
- Hedgehog signal transduction by Smoothened: Pharmacologic evidence for a 2-step activation process
- (2009) R. Rohatgi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
- (2009) R. L. Yauch et al. SCIENCE
- Mechanisms of Hedgehog pathway activation in cancer and implications for therapy
- (2009) Suzie J. Scales et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Hedgehog Signaling in Development and Cancer
- (2008) Jin Jiang et al. DEVELOPMENTAL CELL
- Hedgehog-Induced Survival of B-Cell Chronic Lymphocytic Leukemia Cells in a Stromal Cell Microenvironment: A Potential New Therapeutic Target
- (2008) G. V. Hegde et al. MOLECULAR CANCER RESEARCH
- Notch tumor suppressor function
- (2008) G P Dotto ONCOGENE
- Nevoid basal cell carcinoma syndrome (Gorlin syndrome)
- (2008) Lorenzo Lo Muzio Orphanet Journal of Rare Diseases
- Hedgehog signaling overrides p53-mediated tumor suppression by activating Mdm2
- (2008) Y. Abe et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hedgehog Serves as a Mitogen and Survival Factor During Embryonic Stem Cell Neurogenesis
- (2008) Chunyu Cai et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation